HYPOSIB - Hypofractionation with simultaneous-integrated Boost versus Standard Fractionation in Breast Cancer: The largest randomized, controlled Radiotherapy-Study in Germany - An Intermediate Result

Krockenberger K.; Dunst J.; Loley C.; Olbrich D.; Ziegler A.; Dellas K.

首页> 外文期刊>Strahlentherapie und Onkologie >HYPOSIB - Hypofractionation with simultaneous-integrated Boost versus Standard Fractionation in Breast Cancer: The largest randomized, controlled Radiotherapy-Study in Germany - An Intermediate Result

【24h】

HYPOSIB - Hypofractionation with simultaneous-integrated Boost versus Standard Fractionation in Breast Cancer: The largest randomized, controlled Radiotherapy-Study in Germany - An Intermediate Result

机译：HypoSib - 具有同时整体增压与乳腺癌标准分级的低次级分级：德国中最大的随机受控放射治疗 - 中间结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Strahlentherapie und Onkologie》 |2016年第1期|共2页
作者
Krockenberger K.; Dunst J.; Loley C.; Olbrich D.; Ziegler A.; Dellas K.;
展开▼
作者单位

Univ Lubeck ZKS Lubeck Lubeck Germany;

Univ Klinikum Schleswig Holstein Klin Strahlentherapie Kiel &

Lubeck Kiel Germany;

Univ Lubeck Univ Klinikum Schleswig Holstein Inst Med Biometrie &

Stat Campus Lubeck Lubeck;

Univ Lubeck ZKS Lubeck Lubeck Germany;

Univ Lubeck ZKS Lubeck Lubeck Germany;

Univ Klinikum Schleswig Holstein Klin Strahlentherapie Kiel &

Lubeck Kiel Germany;

展开▼
收录信息
原文格式 PDF
正文语种 ger
中图分类放射医学;
关键词

相似文献

外文文献
专利

1. HYPOSIB - Hypofractionation with simultaneous-integrated Boost versus Standard Fractionation in Breast Cancer: The largest randomized, controlled Radiotherapy-Study in Germany - An Intermediate Result [J] . Krockenberger K., Dunst J., Loley C., Strahlentherapie und Onkologie . 2016,第Suppla1期

机译：HypoSib - 具有同时整体增压与乳腺癌标准分级的低次级分级：德国中最大的随机受控放射治疗 - 中间结果
2. Adjuvant Radiotherapy after breast conserving Surgery in Breast Cancer: Hypofractionation with simultaneous-integrated Boost versus Standard-Fractionation: The multicenter, randomized, controlled Phase-III-Therapy Optimizing Study HYPOSIB starts now [J] . Dellas K., Krockenberger K., Tereszczuk J., Strahlentherapie und Onkologie . 2015,第Suppla1期

机译：乳腺癌保乳手术后的辅助放疗：同时合并Boost与标准分流的超分割术：HYPOSIB的多中心，随机，对照III期治疗优化研究现已开始
3. HYPOSIB - Hypofractionation with simultaneous integrated Boost versus Standard Fractionation in Patients with Breast Cancer: Intermediate Result after successful Recruitment Completion [J] . Dellas K., Olbrich D., Vonthein R., Strahlentherapie und Onkologie . 2019,第Suppla1期

机译：Hyposib - 具有同时集成增压与乳腺癌患者的标准分级的低次级分级：成功招聘完成后中间结果
4. Breast Cancer Risk Prediction using XGBoost and Random Forest Algorithm [C] . Sajib Kabiraj, M. Raihan, Nasif Alvi, International Conference on Computing, Communication and Networking Technologies . 2020

机译：使用XGBoost和随机森林算法的乳腺癌风险预测
5. Hypotensive resuscitation versus standard fluid resuscitation for the management of trauma patients in hemorrhagic shock: The safety phase of a randomized controlled trial. [D] . Morrison, C. Anne. 2009

机译：低血压复苏与标准液体复苏在失血性休克中对创伤患者的处理：一项随机对照试验的安全性阶段。
6. Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery [O] . CEM ONAL, ESMA EFE, OZAN C. GULER, 2019

机译：保乳手术治疗的早期乳腺癌患者序贯与同时整合Boost的剂量学比较
7. Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial [O] . David Krug, Reinhard Vonthein, Andreas Schreiber, 2020

机译：准则对随机对照次吡吡吡吡吡吡吡吡吡吡吡吡吡吡吡吡吡吡吡吡吡吡甲患者特征采用的影响

HYPOSIB - Hypofractionation with simultaneous-integrated Boost versus Standard Fractionation in Breast Cancer: The largest randomized, controlled Radiotherapy-Study in Germany - An Intermediate Result

著录项

相似文献

相关主题

期刊订阅